Therma Bright Inc
XTSX:THRM

Watchlist Manager
Therma Bright Inc Logo
Therma Bright Inc
XTSX:THRM
Watchlist
Price: 0.055 CAD -8.33% Market Closed
Market Cap: CA$3.1m

Therma Bright Inc
Accounts Payable

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Therma Bright Inc
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Therma Bright Inc
XTSX:THRM
Accounts Payable
CA$1m
CAGR 3-Years
46%
CAGR 5-Years
37%
CAGR 10-Years
3%
Profound Medical Corp
TSX:PRN
Accounts Payable
$1.6m
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
8%
Theralase Technologies Inc
XTSX:TLT
Accounts Payable
CA$1m
CAGR 3-Years
25%
CAGR 5-Years
16%
CAGR 10-Years
2%
MedMira Inc
XTSX:MIR
Accounts Payable
CA$3.2m
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
5%
O
Ondine Biomedical Inc
LSE:OBI
Accounts Payable
CA$1.6m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Conavi Medical Corp
XTSX:CNVI
Accounts Payable
$4.9m
CAGR 3-Years
-11%
CAGR 5-Years
2%
CAGR 10-Years
-6%
No Stocks Found

Therma Bright Inc
Glance View

Market Cap
3.1m CAD
Industry
Health Care

Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is a developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other diagnostic and medical device technologies that help test for illnesses and assist with pain management. The firm is focused on providing consumers and medical professionals with solutions that addresses medical and healthcare challenges. The company also provides a technology that delivers non-invasive, and pain-free skincare. Its product offerings include AcuVid, which is an antigen and antibody rapid screening test for COVID-19; Venowave, is a Deep Vein Thrombosis (DVT) prevention pump specifically designed for use at home; InterceptCS, is a system that provides controlled topical heat without the risk of burning the skin; Benepod, is a hot and cold contrast therapy device for pain relief without pain relieving medication, and TherOZap, provides pain management relief using thermal therapy for insect bites and stings.

THRM Intrinsic Value
0.006 CAD
Overvaluation 89%
Intrinsic Value
Price CA$0.055

See Also

What is Therma Bright Inc's Accounts Payable?
Accounts Payable
1m CAD

Based on the financial report for Oct 31, 2025, Therma Bright Inc's Accounts Payable amounts to 1m CAD.

What is Therma Bright Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
3%

Over the last year, the Accounts Payable growth was 12%. The average annual Accounts Payable growth rates for Therma Bright Inc have been 46% over the past three years , 37% over the past five years , and 3% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett